Clinically, HCC tissues show Piezo1 overexpression (r = 0.68, with metastasis), whereas NSCLC tissues exhibit reduced Piezo1 expression (5-year survival of 62% in high vs. low expression). This evidence concerns the gene PIEZO1 and hepatocellular carcinoma.